What it sells
Agent Platform for Life Sciences
Business model breakdown
Buyer: who owns the budget?
UnverifiedRegulatory affairs manager or head at biotech/pharma/device company.
Trigger: what makes them buy now?
UnverifiedNeed fast, traceable answers on what regulators think (e.g. trial design for FDA and EMA) instead of consultants or manual searching.
Workflow: what inputs become what output?
Ask a regulatory question; Rhizome searches source databases, writes an answer citing up to 1,000 documents and drafts a briefing document.
Distribution: how it reaches customers
Self-serve free tier and credit-card signup plus demo-led Business/Enterprise sales; integrations with Claude, ChatGPT, Copilot, Gemini.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2026 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.